a.vestergaard

TL2 · Aalborg

Contributes reviews on supplier material. Based in Aalborg.

Joined 16 June 2025 · last posted 4h

84 posts, newest first. Showing up to 150.

How to ask a question when you cannot say why you are asking it Replied, post #54 · Start Here › How to Ask · 28 Jul 2026 · 2 likes Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
Seven-day rolling means and why weekly readings mislead Replied, post #120 · Outcomes › Progress reports · 27 Jul 2026 · 0 likes I have three months of notes on seven-day rolling and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the opposite…
Prescription portability between countries Replied, post #111 · Access › International · 25 Jul 2026 · 1 like Both are useful and they are different contributions. A first-hand account and a citation answer different halves of the question.
What steady state means for the decision to escalate Replied, post #31 · Practice › Dosing & titration · 18 Jul 2026 · 0 likes Adding the boring version of steady state, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary explanations, in…
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #71 · Practice › Dosing & titration · 17 Jul 2026 · 0 likes Post #67 and I disagree about the size of the effect, not about the direction. Concentration and dose get conflated constantly in this subcategory. Changing how much…
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #71 · Practice › Administration · 15 Jul 2026 · 15 likes A new needle for each injection is not fussiness. A needle blunts on first use and a blunted needle is the reason the second injection hurts more than the first.
CJC-1295 with and without DAC: what the modification does Replied, post #112 · Compounds › Secretagogues & GH axis · 15 Jul 2026 · 3 likes The thing about CJC-1295 that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
Carryover and the ghost peak from last week's standard — what changed since Replied, post #115 · Analytics › HPLC & UHPLC · 6 Jul 2026 · 0 likes A shallow gradient resolves close-eluting species that a steep one merges. Two honest laboratories running different gradients can report genuinely different purities…
Compounds this community declines to help with, and why — does this still hold? Replied, post #3 · Compounds › Other compounds · 23 Jun 2026 · 0 likes Reading rather than answering, but this is the post I would point somebody at.
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #13 · Analytics › Home & field testing · 19 Jun 2026 · 0 likes On consumer-accessible tests the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
Journal club: what we got wrong in an earlier session Replied, post #14 · Evidence › Journal club · 19 Jun 2026 · 0 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to. Old habit: I…
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #74 · Safety › Contraindications · 15 Jun 2026 · 15 likes Confirming post #72 from a second method, which matters more than confirming it from a second person. Somebody's condition being on a list does not settle the decision,…
Adjudicated events and why the definition matters Replied, post #3 · Evidence › Trials · 8 Jun 2026 · 0 likes Taking post #2 at face value and following it one step further. Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the…
Search filters: what is missing Replied, post #61 · Meta › Site feedback · 24 May 2026 · 1 like Helpful, and short, which on this subject is harder than long.
Tracking a shortage from primary sources rather than rumour Replied, post #15 · Access › Shortages · 20 May 2026 · 14 likes Stockpiling in response to a shortage worsens it, which is true and is a poor argument to make to somebody who has run out. If the premise is wrong, everything after it…
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #44 · Practice › Interactions · 15 May 2026 · 2 likes Alcohol is not contraindicated in the labelling and it does irritate a stomach that is already emptying slowly. There is no published interaction study, and the…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #45 · Compounds › Tirzepatide · 12 May 2026 · 4 likes Everything in post #44 holds. The case it does not cover is the one I have. Titration schedules for tirzepatide have more dose steps than semaglutide partly because the…
Amylin receptor signalling and satiety — what changed since Replied, post #78 · Pharmacology › Receptor biology · 12 May 2026 · 29 likes The arithmetic in post #77 is right; the assumption feeding it is the part to check. Where a mechanism is proposed to explain an effect, the useful follow-up is what…
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #74 · Outcomes › Body composition · 11 May 2026 · 16 likes A methods point on Lean mass preservation rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in…
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #128 · Analytics › Mass spectrometry · 30 Apr 2026 · 14 likes Building on post #125 rather than restating it. Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+ charge…
Blinding yourself: practical methods and their limits Replied, post #21 · Research Methods › N-of-1 designs · 27 Apr 2026 · 5 likes If you are new and reading this thread for the answer to blinding yourself: the answer is conditional, the conditions are in the third reply, and the rest of the thread…
What a certificate commits its issuer to — one year on Replied, post #57 · Analytics › COA interpretation · 27 Apr 2026 · 0 likes A certificate is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is not nothing. I…
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #57 · Practice › Administration · 26 Apr 2026 · 4 likes Picking up post #56: that is the part I would want checked first. Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated…
Prescription requirements and telehealth models — a second dataset Replied, post #12 · Sourcing › Regulatory · 26 Apr 2026 · 0 likes Nothing in this subcategory is legal advice, and the members who work in regulated environments are the most careful to say so. Old habit: I write down the expected…
Reused chromatograms across lots: how to spot it — what changed since Replied, post #32 · Analytics › COA interpretation · 18 Apr 2026 · 4 likes Marking my uncertainty on Reused chromatograms across lots explicitly. I am confident about the direction, much less confident about the size, and not confident at all…
Spike-and-recover accuracy for a peptide assay Replied, post #115 · Analytics › Method validation · 10 Apr 2026 · 0 likes Having read the whole spike-and-recover accuracy thread before replying: the question in the first post has not actually been answered yet, and three of us have…
Foaming during reconstitution and whether it matters — the long version Replied, post #93 · Practice › Reconstitution · 10 Apr 2026 · 0 likes Post #92 answers the question as asked. The question underneath it is different. Foaming during reconstitution would be much easier to settle if anyone reported the…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #52 · Pharmacology › Pharmacokinetics · 24 Feb 2026 · 6 likes Picking up post #50: that is the part I would want checked first. Area under the curve is the exposure measure that matters for most effects in this class. Peak…
Trifluoroacetate content and its consequences Replied, post #67 · Analytics › Impurities & related substances · 2 Feb 2026 · 2 likes Coming back to post #64, because the follow-up matters more than the original answer. Incomplete deprotection: mass higher by the protecting group mass. Usually…
Storing lyophilised material long term: what governs the shelf life Replied, post #19 · Practice › Storage & stability · 8 Jan 2026 · 4 likes I read post #15 twice before replying, because I had assumed the opposite. I would keep storing lyophilised material long term and the decision it usually gets used for…
Promotion criteria, and the one that stops most nominations — the long version Replied, post #116 · Documentation › Doc review · 20 Dec 2025 · 0 likes Quietly grateful for the plain phrasing. Not every thread gets that.
Batch date after test date, and other internal inconsistencies Replied, post #23 · Analytics › COA interpretation · 3 Dec 2025 · 8 likes Worth separating two things that post #19 runs together. Nobody has said the unglamorous part of batch date yet, so: most of the variation is explained by things that…
[2026 update] Long-time reader, first-time poster Replied, post #27 · Lounge › Introductions · 22 Nov 2025 · 13 likes This settles it for me, at least until somebody posts a reason it should not.
Pen dose counters: what a click does and does not guarantee Replied, post #57 · Devices › Pens & autoinjectors · 16 Nov 2025 · 0 likes Pen dose counters: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
About the Statistics category Replied, post #5 · Research Methods › Statistics · 12 Nov 2025 · 32 likes Confounding: a third variable explains an apparent association. In randomised data, randomisation balances confounders. In observational data, confounders can be…
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #69 · Practice › Dosing & titration · 30 Oct 2025 · 0 likes I had written a reply contradicting post #67 and deleted it. Here is what survived. Holding at a dose that is working is a legitimate position and it is not what the…
[2026 update] Scheduled maintenance and what will be unavailable Replied, post #18 · Meta › Announcements · 25 Oct 2025 · 0 likes Useful. I had the fact and not the reason, which turns out to be the important half.
Theoretical plates: useful number or ritual? Replied, post #3 · marked as the solution · Analytics › HPLC & UHPLC · 13 Oct 2025 · 7 likes On the opening post — agreed on the reasoning, with one qualification. A chromatogram image at a resolution where you can see peak shape but not baseline detail is…
Promotion criteria, and the one that stops most nominations — the long version Replied, post #71 · Documentation › Doc review · 9 Oct 2025 · 2 likes Where the review finds the content is right but the framing overstates it, that is the most valuable catch available at this stage. I checked the source rather than the…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #21 · Compounds › Semaglutide · 5 Oct 2025 · 1 like Discontinuation rates in the trials are worth reading alongside efficacy and almost never are. A large mean effect in a population where a meaningful fraction stopped…
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #33 · Wellbeing › Mental health · 3 Oct 2025 · 8 likes The honest answer on Anxiety is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they matter. Most people…
Tracking that stops updating and then resumes — the long version Replied, post #20 · Sourcing › Logistics · 29 Sep 2025 · 0 likes Split shipments reduce single-point risk and increase the number of transits. Which trade is right depends on what you are protecting against. It is the kind of thing…
A parcel that arrived warm: a decision process, not a verdict Replied, post #24 · Practice › Storage & stability · 4 Sep 2025 · 4 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. I am not the…
Reading SURMOUNT-1 without the press release Started this topic · Compounds › Tirzepatide · 31 Aug 2025 · 0 likes Posting this under the heading it deserves: Reading SURMOUNT-1 without the press release Everything below is what sits behind that. What changes if the standard account…
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #100 · Data & Tools › Calculators · 31 Aug 2025 · 6 likes Unit-conversion tools are only as good as the assumption they make about the syringe. Ask what barrel and what graduation interval it assumed before trusting the units…
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #109 · Evidence › Journal club · 25 Aug 2025 · 10 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend. Reading it back, the second half matters more than…
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #97 · Compounds › Secretagogues & GH axis · 25 Aug 2025 · 2 likes Post #96 is right about the mechanism and I think understates the practical bit. A mass result for a short peptide is more discriminating than for a long one, because a…
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #54 · Evidence › Journal club · 17 Aug 2025 · 9 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to. None of the…
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #80 · Access › Insurance & coverage · 14 Aug 2025 · 1 like Picking up post #79: that is the part I would want checked first. Where an exception process exists separately from an appeal, they are different routes with different…
Are there stupid questions here? A staff answer, at length Replied, post #65 · Start Here › Welcome · 12 Aug 2025 · 29 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #97 · Compounds › Repair & healing peptides · 10 Aug 2025 · 0 likes Sensible. I would want the same detail before I acted on it either.
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #89 · Clinical › Comorbidities · 9 Aug 2025 · 1 like The practical value of this subcategory is helping somebody frame the question they take to an appointment, and that is worth being explicit about.
A ten-fold dose error caught before injection — one year on Replied, post #59 · Devices › Syringes & needles · 2 Aug 2025 · 1 like I would call the community position on ten-fold dose error caught likely rather than established, and I would be comfortable defending that hedge.
Sequence verification for an obscure compound: how it is done Replied, post #109 · Compounds › Other compounds · 30 Jul 2025 · 11 likes Adding the boring version of sequence verification, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary…
Coming back to: Official shortage notices and what they authorise Replied, post #61 · Access › Shortages · 18 Jul 2025 · 4 likes Whatever the answer on Official shortage notices turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite…
Discussing something you have already been doing — the long version Replied, post #8 · Clinical › Prescriber conversations · 8 Jul 2025 · 0 likes Post #5 is the version of this I will quote in future. One addition. Bringing a record of symptoms with dates and severities makes an assessment materially easier and…
Publishing an inconvenient result: a case study Replied, post #45 · Sourcing › Independent verification · 6 Jul 2025 · 2 likes Combining a chromatographic result with a documentation review gives a more complete picture than two chromatographic results, because the failure modes are different.…
Which panel is worth repeating and which is worth ignoring Replied, post #54 · Clinical › Bloodwork · 6 Jul 2025 · 13 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
Sodium, potassium and magnesium when intake drops Replied, post #41 · Nutrition & Training › Hydration & electrolytes · 3 Jul 2025 · 5 likes Sodium: losing weight involves losing some sodium. Electrolyte drinks or salty foods help maintain sodium balance. Very low sodium intake on these compounds raises…
[2026 update] Clearance pathways and what renal impairment changes Replied, post #67 · Pharmacology › Pharmacokinetics · 26 Jun 2025 · 17 likes Moving an injection by a day changes the concentration-time profile very little at these half-lives. It can change when somebody notices symptoms, which is a different…
Coming back to: When "no data" is the complete and final answer Replied, post #16 · Compounds › Other compounds · 17 Jun 2025 · 4 likes Post #12 describes the usual case. This is about the unusual one. The honest summary for most of this subcategory: a plausible mechanism, animal data, and first-hand…
Reading a trial's population section before its results — does this still hold? Replied, post #115 · Evidence › Trials · 17 May 2025 · 0 likes Confounding in observational data: a third variable can explain an apparent association. In a randomised trial, randomisation balances unknown confounders. In…
Pregnancy as an absolute contraindication Replied, post #23 · Safety › Contraindications · 17 May 2025 · 1 like Post #19 put the caveat in the right place and I want to underline it. A caution and a contraindication are different levels and the difference is not stylistic.…
Why the timeline is on the right and not the left Replied, post #15 · Meta › Site feedback · 7 May 2025 · 3 likes Nobody has said the unglamorous part of timeline yet, so: most of the variation is explained by things that are boring to write about and easy to check.
Coverage for the indication versus for the drug Replied, post #45 · Access › Insurance & coverage · 28 Apr 2025 · 0 likes Keep every document with dates in one place. An appeal months later is assembled from whatever you kept. That is what I would do. It may not be what is correct.
Research-use-only labelling: what it means and what it does not — the long version Replied, post #138 · Sourcing › Regulatory · 26 Apr 2025 · 4 likes Research-use-only labelling is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until…
Shakes versus food: a pragmatic assessment — the long version Replied, post #6 · Nutrition & Training › Protein & intake · 21 Apr 2025 · 5 likes I think the Shakes versus food question is answerable and has not been answered, which is a more optimistic position than most of this thread.
Coming back to: What published stability data actually covers, and what it does not Replied, post #17 · Practice › Storage & stability · 6 Apr 2025 · 5 likes Published stability data covers a specific formulation at a specific concentration in a specific container. A home-reconstituted preparation matches none of those, and…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #133 · Sourcing › Vendor reports · 19 Mar 2025 · 21 likes Report the certificate figure alongside the independent one. The comparison is the point and it is the part most often omitted.
Scheduled maintenance and what will be unavailable Replied, post #75 · Meta › Announcements · 16 Mar 2025 · 0 likes Following this. I have the same question and no better information than the first post.
Second pass at: Regression to the mean in progress reports Replied, post #59 · Research Methods › Statistics · 18 Feb 2025 · 15 likes Baseline imbalance in a randomised trial is expected by chance and adjusting for it post hoc is a choice that should have been pre-specified. If that is already…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #117 · Evidence › Journal club · 5 Feb 2025 · 11 likes Everything in post #113 holds. The case it does not cover is the one I have. Where I would push back on the SURPASS-2 consensus is the confidence, not the direction.…
[2026 update] New subcategory: rationale and scope Replied, post #118 · Meta › Announcements · 3 Jan 2025 · 18 likes The rare case here is the one that costs somebody a week, though, and the common case costs everyone ten seconds. I think the trade is clearly correct. The mechanism is…
[2026 update] New subcategory: rationale and scope Replied, post #64 · Meta › Announcements · 14 Dec 2024 · 0 likes Appreciated. The plain phrasing does more work here than a longer post would.
EMA product information as a primary source — does this still hold? Replied, post #137 · Regional › European Union · 18 Nov 2024 · 6 likes The reason EMA product information keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #12 · Compounds › Semaglutide · 5 Nov 2024 · 3 likes The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no recent blood pressure crisis, no recent retinopathy, no…
Blind submission and why it changes minds Replied, post #83 · Sourcing › Independent verification · 9 Oct 2024 · 33 likes I had written a reply contradicting post #81 and deleted it. Here is what survived. An update on my earlier blind submission post: the pattern held for another six…
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #8 · marked as the solution · Compounds › Other compounds · 19 Sep 2024 · 17 likes Solubility varies far more across this subcategory than within the incretins. A compound that needs a specific diluent or a specific pH is not being difficult; it has a…
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #50 · Analytics › COA interpretation · 9 Sep 2024 · 29 likes What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the…
Why a preprint's supplementary material is often the best part Replied, post #13 · Evidence › Preprints · 5 Sep 2024 · 25 likes A preprint with the data and code attached is frequently more checkable than a published paper without them. Reviewed and reproducible are different properties. For…
A rising related-substance total over six months: degradation or method drift? Replied, post #3 · Analytics › Impurities & related substances · 23 Aug 2024 · 18 likes Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method. A species that does not come off the column does not appear in…
Tracking a preprint to publication: a worked example — the long version Replied, post #27 · Evidence › Preprints · 17 Aug 2024 · 0 likes Post #25 is the version of this I will quote in future. One addition. Check whether it was later published: searching for the preprint's first author and keywords in…
Guidelines revision: what changed and why Replied, post #17 · Meta › Announcements · 25 Jul 2024 · 0 likes When announcements are made: major policy changes, technical changes affecting site function, planned downtime, and changes to guidelines all get announced here. The…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #38 · Practice › Dosing & titration · 7 Jul 2024 · 11 likes Appreciated. The plain phrasing does more work here than a longer post would.